Viracta Therapeutics Stock Quote VIRX - Stock Price, News, Charts, Message Board, Trades

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.70

Bid

0.6725

Ask

0.8527

Volume

47,782

0.68 Day's Range 0.75

0.43 52 Week Range 1.77

Market Cap

27.491M

Previous Close

0.6901

Open

0.681

Last Trade

0.7

Last Trade Time

Financial Volume

$ 33,758

VWAP

0.706508

Average Volume (3m)

97,863

Shares Outstanding

39,272,434

Dividend Yield

PE Ratio

-0.54

Earnings Per Share (EPS)

-1.3

Revenue

Net Profit

-51.06M

Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein... Viracta Therapeutics Inc is a precision oncology company, focused on the development of new medicines targeting virus-associated malignancies. The company is conducting three clinical trials for its combination product candidate as a potential therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. Its lead product candidate is a combination product candidate consisting of nanatinostat, a potent and selective small molecule inhibitor of class I histone deacetylases (HDAC), and valganciclovir, an FDA-approved anti-viral drug used to treat and prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.viracta.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Viracta Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VIRX. The last closing price for Viracta Therapeutics was $0.69. Over the last year, Viracta Therapeutics shares have traded in a share price range of $ 0.43 to $ 1.77.

Viracta Therapeutics currently has 39,272,434 shares outstanding. The market capitalization of Viracta Therapeutics is $27.49 million. Viracta Therapeutics has a price to earnings ratio (PE ratio) of -0.54.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.063	-8.25688073394	0.763	0.8	0.6615	62846	0.70247629	CS
4	-0.1212	-14.7588894301	0.8212	0.8938	0.6615	57582	0.77681229	CS
12	-0.13	-15.6626506024	0.83	1.31	0.6615	97863	0.931064	CS
26	0.202	40.562248996	0.498	1.31	0.43	126771	0.69978514	CS
52	-0.65	-48.1481481481	1.35	1.77	0.43	118356	0.91221208	CS
156	-9.3	-93	10	13.08	0.43	178749	3.90043293	CS
260	-16.06	-95.8233890215	16.76	18.24	0.43	194516	4.8414186	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NVOSNovo Integrated Sciences Inc	$ 1.05 (132.82%)	310.28M
BNAIBrand Engagement Network Inc	$ 5.4799 (112.40%)	67.99M
PRTGPortage Biotech Inc	$ 0.51 (98.44%)	4.26M
PLTNUPlutoniam Acquisition Corporation	$ 12.06 (81.63%)	1.81k
PEGRUProject Energy Reimagined Acquisition Corporation	$ 11.43 (36.89%)	1.19k
WBUYWeBuy Global Ltd	$ 0.241 (-61.75%)	22.54M
SMFLSmart for Life Inc	$ 3.40 (-43.05%)	2.77M
TOIIWOncology Institute Inc	$ 0.016 (-40.74%)	5.5k
SIFYSify Technologies Limited	$ 1.105 (-34.23%)	3.69M
LOTLotus Technology Inc	$ 9.78 (-25.00%)	832.27k
NVOSNovo Integrated Sciences Inc	$ 1.05 (132.82%)	310.28M
GWAVGreenwave Technology Solutions Inc	$ 0.0387 (-7.86%)	305.13M
FFIEFaraday Future Intelligent Electric Inc	$ 0.584899 (3.47%)	223.84M
SQQQProShares UltraPro Short QQQ	$ 10.02 (0.00%)	161.89M
CRKNCrown Electrokinetics Corporation	$ 0.0998 (-12.07%)	155.13M